RxDoctor Payments DataLook up a doctor →

Seth Barnes, MD

Internal Medicine · Hot Springs, ARNPI 1417958919

Payments from drug & device makers

$8,759in general payments, 2019–2025

Across 624 payments — averaging $14.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Abbott$683
  • Novo Nordisk$610
  • Lilly USA, LLC$603
  • GSK$596
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$8,747100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,759 in reported general payments places this provider in the 90th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$239,214
Medicare patients
820
Services billed
12,816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban163$165,275
OzempicSemaglutide145$147,392
XareltoRivaroxaban55$75,272
JanuviaSitagliptin Phosphate65$66,422
JardianceEmpagliflozin62$61,768
TrulicityDulaglutide37$59,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$46,279
RexultiBrexpiprazole20$43,480
JulucaDolutegravir/Rilpivirine12$42,367
MounjaroTirzepatide37$38,933
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen717$24,282
LinzessLinaclotide37$21,171
Tresiba Flextouch U-100Insulin Degludec25$19,147
Repatha SureclickEvolocumab13$15,556
Fentanyl41$14,811

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$311$175,983189 claims
Novo NordiskOzempic$610$147,392145 claims
Lilly USA, LLCTrulicity, Mounjaro$603$98,62174 claims
Johnson & JohnsonXarelto$62$75,27255 claims
Boehringer IngelheimJardiance, Spiriva Respimat$105$73,08282 claims
MerckJanuvia$55$66,42265 claims
GSKTrelegy Ellipta, Anoro Ellipta$596$52,36479 claims
Otsuka America Pharmaceutical, Inc.Rexulti$313$43,48020 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$1,024$31,48968 claims
AbbVieLinzess, Synthroid$1,620$26,466115 claims
Astellas Pharma US IncMyrbetriq$89$11,04920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →